Sanofi and Partners Win Approval for Sleeping Sickness Drug and Score Valuable Priority Review Voucher

Sanofi and nonprofit partners in Africa have won FDA approval for the first oral treatment for sleeping sickness. In addition to the approval, the FDA granted the partners a priority review voucher (PRV) worth millions of dollars.
Source: Drug Industry Daily